Search Results

61 - 70 of 82 items :

  • pharmacokinetics x
  • Life Sciences x
Clear All
Study of troponin, creatine kinase biomarkers, and histopathological lesions in experimental Nerium oleander toxicity in rats and mice

20 Narayane V.S., Pawakar A.P., Souza A.A., Karande H.A.: Toxicity studies on Nerium oleander leaf extract in male albino mice: an approach to develop oral contraceptive. J Herb Med Toxicol 2009, 3, 95–104. Narayane V.S. Pawakar A.P. Souza A.A. Karande H.A. Toxicity studies on Nerium oleander leaf extract in male albino mice: an approach to develop oral contraceptive J Herb Med Toxicol 2009 3 95 104 21 Ni D., Madden T.L., Johansen M., Felix E., Ho D.H., Newman R.A.: Murine pharmacokinetics and metabolism of oleandrin, a cytotoxic component of Nerium oleander

Open access
Genotoxicity and mutagenicity of inosine pranobex

pharmacokinetic properties, and therapeutic efficacy. Drugs 1986, 32, 383–424. Campoli-Richards D.M. Sorkin E.M. Heel R.C. Inosine pranobex A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1986 32 383 – 424 4 Fang J.L., Beland F.A.: Long-term exposure to zidovudine delays cell cycle progression, induces apoptosis, and decreases telomerase activity in human hepatocytes. Toxicol Sci 2009, 111, 120–130. 10.1093/toxsci/kfp136 Fang J.L. Beland F.A. Long-term exposure to zidovudine delays cell cycle

Open access
Effects of natural antioxidants on the stability of omega-3 fatty acids in dog food

. Food Chem 2009, 112, 551–559. 10.1016/j.foodchem.2008.06.005 Maier T. Schieber A. Kammerer D.R. Carle R. Residues of grape ( Vitis vinifera L.) seed oil production as a valuable source of phenolic antioxidants Food Chem 2009 112 551 559 24 Mertens-Talcott S.U., Rios J., Jilma-Stohlawetz P., Pacheco-Palencia L.A., Meibohm B., Talcott S.T., Derendorf H.: Pharmacokinetics of anthocyanins and antioxidant effects after the consumption of anthocyanin-rich acai juice and pulp ( Euterpe oleracea Mart.) in human healthy volunteers. J Agric Food Chem 2008, 56, 7796

Open access
Anthelmintic resistance in parasites of small ruminants: sheep versus goats

)90059-0 [31] Hennessy, D. R., Sangster, N. C., Steel, J. W., Collins, G. H. (1993): Comparative pharmacokinetic behaviour of albendazole in sheep and goats. Int. J. Parasitol., 23: 321–325. DOI: 10.1016/0020-7519(93)90006-K http://dx.doi.org/10.1016/0020-7519(93)90006-K [32] Hertzberg H., Bauer C. (2000): Anthelminthika-Resistenzen bei Magen-Darm Strongyliden von Schafen und Ziegen: Aktuelles ueber Verbreitung, Epidemiologie, Vorbeugemaßnahmen und Alternativen zum Anthelminthika- Einsatz. Berl. Muench. Tieraerztl. Wsch., 113: 122

Open access
Safety of concomitant treatment with Non-Vitamin K Oral Anticoagulants and SSRI/SNRI antidepressants

, Mancuso A, Andò G, et al. Pharmacokinetics of new oral anticoagulants: implications for use in routine care. Expert Opin Drug Metab Toxicol. 2018; 14:1057-1069. 5. Dexxience [EU]. BevyxXa [US] · Venous thromboemolism (VTE) prevention - first line - in at risk adult patients hospitalised for an acute medical illness [Cited 13.01.2019]. Accessible at: https://www.sps.nhs.uk/medicines/betrixaban/ 6. Gelosa P, Castiglioni L, Tenconi M, Baldessin L, Racagni G, Corsini A, et al. Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants

Open access
Unexpected bleeding after Exenatide treatment: a causative relationship or a coincidence?

, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30, 239–245, 1981. Soon D, Kothare PA, Linnebjerg H, Park S, Yuen E, Mace KF, Wise SD. Effect of exenatide on the pharmacokinetics and pharmacodynamics of warfarin in healthy Asian men. J Clin Pharmacol 46, 1179–1187, 2006. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes

Open access
Adverse eff ects of polymeric nanoparticle poly(ethylene glycol)- block-polylactide methyl ether (PEG-b-PLA) on steroid hormone secretion by porcine granulosa cells

drug carriers. Adv Clin Exp Med 24, 749-758, 2015. Oberdoster G. Safety assessment for nanotechnology and nanomedicine: concept of nanotoxicology. J Intern Med 267, 89-105, 2009. Patel T, Zhou J, Piepmeier JM, Saltzman WM. Polymeric nanoparticles for drug delivery to the central nervous system. Adv Drug Deliv Rev 163, 93-99, 2012. Pelham RW, Nix LC, Chavira RE, Cleveland MVB, Stetson P. Clinical trial: si ngle- and multiple-dose pharmacokinetics of polyethylene glycol (PEG-3350) in young and elderly subjects. Aliment

Open access
Adriamycin - efficacy and possible adverse effects

): 270-281. 8. Wcisło G., Korniluk J., Szarlej-Wcisło K., Pawlak W.Z., Nurzyński P., Duchnowska R.: Leczenie chorób nowotworowych czynnikiem martwicy nowotworów – alfa (TNF-alfa). Współczesna Onkologia, 2002; 4: 222–227. 9. Gabizon et al . Pharmacokinetics of Pegylated Liposomal Doxorubicin Review of Animal and Human Studies. Clin Pharmacokinet 2003; 42 (5): 419-436. 10. National Institute for Health and Clinical Excellence; TA91 Ovarian cancer (advanced) - paclitaxel, pegylated liposomal doxorubicin hydro-chloride and topotecan (review): Guidance

Open access
Wenetoklaks w leczeniu chorób układu krwiotwórczego i guzów litych

Robak T Pharmacodynamic considerations of small molecule targeted therapy for treating B-cell malignancies in the elderly Expert Opin Drug Metab Toxicol 2015 11 1371 91 [11] Wilson WH, O’Connor OA, Czuczman MS, et al. Navitoclax, a targeted high affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. Lancet Oncol 2010;11:1149-59. 21094089 10.1016/S1470-2045(10)70261-8 Wilson WH O’Connor OA Czuczman MS et al Navitoclax, a targeted high

Open access
Procedural Sedation and Analgesia in Adults - new trends in patients safety

, MacDonald K. Im­proving patient safety during procedural sedation via respiratory volume monitoring: A randomized controlled trial. Journal of Clinical Anesthesia. 2018; 46:118-123. 25. Kilicaslan A, Gok F, Gunuc H. Continous monitoring of ventilation by diaphragm ul­trasonography using a new tool during pro­cedural sedation. Journal of Clinical Anes­thesia. 2018; 50:12-13. 26. Gan T. Pharmacokinetic and Pharmacody­namic Characteristics of Medications Used for Moderate Sedation. Clinical Pharmaco­kinetics. 2006; 45

Open access